These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1340 related articles for article (PubMed ID: 16862189)

  • 1. Drug penetration in solid tumours.
    Minchinton AI; Tannock IF
    Nat Rev Cancer; 2006 Aug; 6(8):583-92. PubMed ID: 16862189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The penetration of anticancer drugs through tumor tissue as a function of cellular adhesion and packing density of tumor cells.
    Grantab R; Sivananthan S; Tannock IF
    Cancer Res; 2006 Jan; 66(2):1033-9. PubMed ID: 16424039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidrug resistance in cancer therapy: role of the microenvironment.
    Galmarini CM; Galmarini FC
    Curr Opin Investig Drugs; 2003 Dec; 4(12):1416-21. PubMed ID: 14763126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect.
    Maeda H; Bharate GY; Daruwalla J
    Eur J Pharm Biopharm; 2009 Mar; 71(3):409-19. PubMed ID: 19070661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical issues in site-specific targeting of solid tumours: the carrier, the tumour barriers and the bioavailable drug.
    Hamad I; Moghimi SM
    Expert Opin Drug Deliv; 2008 Feb; 5(2):205-19. PubMed ID: 18248319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticles for delivery of chemotherapeutic agents to tumors.
    Vijayaraghavalu S; Raghavan D; Labhasetwar V
    Curr Opin Investig Drugs; 2007 Jun; 8(6):477-84. PubMed ID: 17621878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penetration of anticancer drugs through solid tissue: a factor that limits the effectiveness of chemotherapy for solid tumors.
    Tunggal JK; Cowan DS; Shaikh H; Tannock IF
    Clin Cancer Res; 1999 Jun; 5(6):1583-6. PubMed ID: 10389947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Target selectivity of anticancer drugs].
    Fattoruso SI; Di Lauro L; Conti F; Amodio A; Lopez M
    Clin Ter; 2008; 159(3):189-206. PubMed ID: 18594750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug delivery to tumours: recent strategies.
    Reddy LH
    J Pharm Pharmacol; 2005 Oct; 57(10):1231-42. PubMed ID: 16259751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The distribution of the anticancer drug Doxorubicin in relation to blood vessels in solid tumors.
    Primeau AJ; Rendon A; Hedley D; Lilge L; Tannock IF
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8782-8. PubMed ID: 16361566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour-targeted drug and gene delivery: principles and concepts.
    Cassidy J; Schätzlein AG
    Expert Rev Mol Med; 2004 Sep; 6(19):1-17. PubMed ID: 15387893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour targeting: biological factors and formulation advances in injectable lipid nanoparticles.
    Shenoy VS; Vijay IK; Murthy RS
    J Pharm Pharmacol; 2005 Apr; 57(4):411-22. PubMed ID: 15831200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand-based targeted therapy for cancer tissue.
    Das M; Mohanty C; Sahoo SK
    Expert Opin Drug Deliv; 2009 Mar; 6(3):285-304. PubMed ID: 19327045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical mechanisms and methods employed in drug delivery to tumors.
    Besić E
    Acta Pharm; 2007 Sep; 57(3):249-68. PubMed ID: 17878107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous and induced oxidative stress in multi-cellular tumour spheroids: implications for improving tumour therapy.
    Khaitan D; Dwarakanath BS
    Indian J Biochem Biophys; 2009 Feb; 46(1):16-24. PubMed ID: 19374249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifactorial nature of tumor drug resistance.
    Solyanik GI
    Exp Oncol; 2010 Sep; 32(3):181-5. PubMed ID: 21403614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical evaluation of molecular-targeted anticancer agents for radiotherapy.
    Krause M; Zips D; Thames HD; Kummermehr J; Baumann M
    Radiother Oncol; 2006 Aug; 80(2):112-22. PubMed ID: 16916560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing the pathophysiology of solid tumours: the potential of TNF and other vasoactive agents.
    ten Hagen TL; Eggermont AM
    Int J Hyperthermia; 2006 May; 22(3):241-6. PubMed ID: 16754345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Freezing-assisted intracellular drug delivery to multidrug resistant cancer cells.
    Teo KY; Han B
    J Biomech Eng; 2009 Jul; 131(7):074513. PubMed ID: 19640149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivering cancer stem cell therapies - a role for nanomedicines?
    Schätzlein AG
    Eur J Cancer; 2006 Jun; 42(9):1309-15. PubMed ID: 16682183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 67.